Managing recurrent, residual or metastatic disease
Strengthen early referral to palliative care for people with advanced pancreatic cancer
Learn more about strategies and associated activities for implementation for this key priority area
Optimal Care Pathway step
Managing recurrent, residual or metastatic disease
The National Pancreatic Cancer Roadmap identifies key priority areas and strategies which focus on improving management of recurrent, residual or metastatic disease
Evidence summary and stakeholder input
The following is a summary of the findings from the evidence gathering activities and stakeholder consultations undertaken to inform development of the Roadmap. For more information on the development of the Roadmap see the About page.
See more
Key priority areas
Managing recurrent, residual or metastatic disease
Increase access and timely referral to specialist multidisciplinary meetings (MDMs) with palliative care representation for people with metastatic pancreatic cancer
Learn more about strategies and associated activities for implementation for this key priority area
Managing recurrent, residual or metastatic disease
Improve equity of access to community-based palliative care services for people with pancreatic cancer
Learn more about strategies and associated activities for implementation for this key priority area
Managing recurrent, residual or metastatic disease
Provide systems and services that support rapid access to palliative care when needed for people with pancreatic cancer
Learn more about strategies and associated activities for implementation for this key priority area